title: Pharmaceutical policies used by private health insurance companies in Saudi Arabia.
abstract: BACKGROUND
  Currently, the Council of Cooperative Health Insurance (CCHI) is the body responsible for regulating health insurance in the KSA. While the cooperative health insurance schedule (i.e., model policy for health insurance) is available on the CCHI web site, policies related to pharmaceuticals are ambiguous.
  
  
  OBJECTIVE
  The primary objective of this study was to assess the impact of health insurance policies provided by health insurance companies in KSA on access to medication and its use.
  
  
  METHODS
  This study was descriptive in design and used a survey, which was conducted through face-to-face interviews with the medical managers of health insurance companies.
  
  
  METHODS
  The survey took place between March and June, 2011. All 25 insurance companies accredited by CCHI were eligible to be included in the study. Out of these 25 companies, three were excluded from this survey as no response was received.
  
  
  RESULTS
  All the 16 companies responded "Yes" that they had a prior authorization policy; however, their reasons varied. Eight (50%) of the companies were concerned about the duration of treatment. While 10 (62.5%) did not offer additional coverage over the CCHI model policy, the other 6 (37.5%) reported that they could reconcile certain conditions. The survey also demonstrated that 10 insurance companies allowed refilling of medication but with certain limitations. Six out of the 10 permitted refilling within a maximum time of three months, whereas the other four companies did not have any time-based limits for refilling. The other six companies did not allow refilling without prescription.
  
  
  CONCLUSIONS
  Although this paper was primarily descriptive, the findings revealed a substantial scope for improvement in terms of pharmaceutical policy standards and regulation in the health insurance companies in KSA. Additionally, the study highlighted such areas to augment the overall quality use of medication, over-prescribing and irrational use of medication. Further research, thus, is definitely needed.
authors: Saudi Food and Drug Authority, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
authors: Saleh A
authors: SA
authors: Bawazir
authors: Mohammed A
authors: MA
authors: Alkudsi
authors: Abdullah S
authors: AS
authors: Al Humaidan
authors: Maher A
authors: MA
authors: Al Jaser
authors: Larry D
authors: LD
authors: Sasich
keywords: Delivery of health care; Health care policy; Health insurance; Saudi Arabia
references: Ann Saudi Med. 1993 Mar;13(2):172-7
references: 17588025
references: BMC Infect Dis. 2006 Jan 10;6:3
references: 16403220
references: Clin Ther. 2012 Apr;34(4):904-14
references: 22417714
references: Drugs Aging. 2011 Oct 1;28(10):797-807
references: 21970307
references: Health Aff (Millwood). 2010 Dec;29(12):2323-34
references: 21088012
references: Ann Saudi Med. 2008 Jul-Aug;28(4):243-50
references: 18596400
references: Dtsch Arztebl Int. 2009 Oct;106(40):641-8
references: 19890430
references: Saudi Med J. 2007 Mar;28(3):369-74
references: 17334461
references: Saudi Med J. 2005 May;26(5):824-9
references: 15951877
references: Health Policy. 2011 May;100(2-3):151-8
references: 20828854
references: Health Policy. 2011 May;100(2-3):134-43
references: 21185616